About 135 hospitals in the U.S. will shift the large majority of their spending on bare-metal and drug-eluting stents to Abbott and Medtronic as part of the first contracts awarded by SharedClarity, a new joint venture that aims to reduce the costs of the most expensive medical devices used in...
Help employers find you! Check out all the jobs and post your resume.
